Sensei Biotherapeutics to execute 1-for-20 reverse stock split

3 weeks ago 1

Sensei Biotherapeutics (NASDAQ:SNSE) will implement a 1-for-20 reverse stock split of its issued and outstanding shares of common stock on June 16, 2025.
The reverse stock split is intended to bring the company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
SNSE -4.65% premarket.
Source: Press Release

Recommended For You